Prévisions du marché européen du diagnostic du cancer du cerveau jusqu’en 2028 – Impact du COVID-19 et analyse régionale par type de diagnostic (test d’imagerie, ponction lombaire, biopsie, tests moléculaires et autres) ; Type de cancer (névrome acoustique, astrocytome, craniopharyngiomes, ganglioneuromes, glioblastome multiforme, méningiomes, épendymomes et autres) ; Utilisateur final (hôpitaux, cliniques spécialisées, centres chirurgicaux ambulatoires et autres)

Introduction au marché

Les cancers du cerveau sont dus à la croissance extracellulaire des cellules du cerveau qui provoquent des tumeurs. La tumeur comprend les tumeurs cérébrales primaires et les tumeurs cérébrales secondaires. Les tumeurs cérébrales primaires se forment dans le cerveau et ne se propagent pas à d\'autres parties du corps, tandis que les tumeurs secondaires, également appelées métastases, sont des cancers qui ont commencé dans une autre partie du corps. Les tumeurs cérébrales sont classées en 40 types principaux, eux-mêmes classés en deux grands groupes : bénins, c\'est-à-dire à croissance lente et ayant moins de chance de se propager, et malins, c\'est-à-dire cancéreux et plus susceptibles de se propager.

< p>Ainsi, l\'augmentation de la prévalence du cancer du cerveau devrait créer une demande importante de diagnostics du cancer du cerveau dans les années à venir, ce qui devrait en outre stimuler le marché du diagnostic du cancer du cerveau.

Les patients atteints de cancer ont ont été négativement touchés par la pandémie de COVID-19, car bon nombre de ces personnes peuvent être immunodéprimées et plus âgées. De plus, les rendez-vous de suivi du cancer ou d’imagerie ont été retardés dans de nombreuses cliniques à travers le monde. Le report des examens de dépistage de routine entraînera des retards dans les diagnostics de nouveaux cancers. Les cliniques continuent de surveiller et d’adapter leurs horaires de rendez-vous en fonction des éclosions locales de COVID-19. Les études sur la COVID-19 chez les patients atteints de cancer sont limitées, mais indiquent systématiquement que cette population est exposée à un risque de maladie COVID-19 plus grave. Les données d’études récentes suggèrent également que les patients pédiatriques atteints de cancer ont un risque plus faible de développer une forme grave de la COVID-19 par rapport aux adultes. Certaines caractéristiques de l\'infection par le SRAS-CoV-2 détectées par l\'imagerie pulmonaire, cérébrale et gastro-intestinale peuvent dérouter les radiologues. interprétation du diagnostic du cancer, de sa stadification et de la réponse au traitement. Enfin, alors que les cliniques commencent à rouvrir pour les rendez-vous de routine, des protocoles ont été mis en place pour réduire l\'exposition des patients au SRAS-CoV-2 lors de leurs visites. Cette revue détaille différentes perspectives sur l\'impact de la pandémie de COVID-19 sur les patients atteints de cancer et sur l\'imagerie du cancer.

Aperçu et dynamique du marché

Le marché du diagnostic du cancer du cerveau en Europe devrait passer de 207,5 millions de dollars US en 2021 à 601,0 millions de dollars US. millions d’ici 2028 ; on estime qu’elle connaîtra une croissance de 16,4 % entre 2021 et 2028. L’intelligence artificielle implique l’utilisation d’ordinateurs puissants pour effectuer des tâches habituellement associées à l’intelligence humaine. Un type d\'intelligence artificielle appelé apprentissage profond utilise des algorithmes mathématiques complexes (parfois appelés réseaux de neurones convolutifs) pour extraire des caractéristiques des données, puis les « entraîner ». Cette formation permet à l\'algorithme de reconnaître des modèles et d\'effectuer des tâches telles que l\'analyse d\'images. Pour combiner les fonctions puissantes de l’imageur SRH avec l’IA, les chercheurs ont commencé à effectuer une formation algorithmique sur les images de tissus de tumeurs cérébrales produites par le SRH. Les chercheurs ont souligné que la capacité de la technologie de l’intelligence artificielle et des pathologistes à se vérifier mutuellement met en évidence la nécessité pour les pathologistes de coopérer avec la technologie de l’intelligence artificielle pour interpréter les cas difficiles et garantir la plus grande précision diagnostique possible. L’imagerie SSR et IA sont des technologies émergentes, leur intégration dans les soins de santé sera donc un défi. La technologie de l’IA permet aux chirurgiens d’identifier rapidement et précisément les zones contenant des tumeurs ou des tissus sains. Ainsi, l\'intelligence artificielle SRH est de plus en plus utilisée pour améliorer le diagnostic des tumeurs cérébrales pendant la chirurgie.

Segments clés du marché

En termes de type de diagnostic, le segment des tests d’imagerie représentait la plus grande part du marché européen du diagnostic du cancer du cerveau en 2020. En termes de type de cancer, le segment du glioblastome multiforme représentait la plus grande part du marché européen du diagnostic du cancer du cerveau en 2020. En termes d’utilisateur final, le segment des hôpitaux représentait la plus grande part du marché européen du diagnostic du cancer du cerveau en 2020.

Principales sources et entreprises répertoriées

Quelques principales sources primaires et secondaires mentionnées pour la préparation de ce rapport sur le marché du diagnostic du cancer du cerveau en Europe sont les sites Web des entreprises, leurs rapports annuels. rapports, rapports financiers, documents du gouvernement national et base de données statistiques, entre autres. Les principales sociétés répertoriées dans le rapport sont Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. et Neusoft Medical Systems.

Raisons acheter le rapport

Comprendre le paysage du marché européen du diagnostic du cancer du cerveau et identifier les segments de marché les plus susceptibles de garantir une forte croissance retour
Gardez une longueur d\'avance en comprenant le paysage concurrentiel en constante évolution du marché européen du diagnostic du cancer du cerveau
Planifiez efficacement les fusions et acquisitions et les accords de partenariat sur le marché européen du diagnostic du cancer du cerveau en identifiant segments de marché avec les ventes probables les plus prometteuses
Aide à prendre des décisions commerciales éclairées à partir d\'une analyse perspicace et complète des performances du marché de divers segments du marché européen du diagnostic du cancer du cerveau
Obtenir les prévisions de revenus du marché pour marché par divers segments de 2021 à 2028 dans la région Europe.

Europe Segmentation du marché des diagnostics du cancer du cerveau

Par type de diagnostic

Test d\'imagerie
- IRM
- TDM
- TEP
Biopsie
Tests moléculaires
Ponction lombaire
Autres

Par type de cancer

Glioblastome multiforme
Astrocytomes
Épendymomes
Autres

Par Utilisateur final

Hôpitaux
Cliniques spécialisées
Centres chirurgicaux ambulatoires
Autres

Par pays

Europe
- Allemagne
- Royaume-Uni
- France
- Espagne
- Italie
- Reste de l\'Europe

< strong>Entreprises mentionnées

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Brain Cancer Diagnostics Market – By End User

1.3.4 Europe Brain Cancer Diagnostics Market – By Country

2. Europe Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Brain Cancer Diagnostics Market- Europe PEST Analysis

4.3 Expert Opinion

5. Europe Brain Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Future Trends

5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4 Impact Analysis

6. Brain Cancer Diagnostics Market – Europe Analysis

6.1 Europe Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7. Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End user

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028

10.1.1 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

10.1.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.2.2.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.2.3 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.2.4 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.3.2.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.3.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.3.4 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.4 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.2 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.4.2.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.4.3 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.4.4 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.5 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.2 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.5.2.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.5.3 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.5.4 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.6 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.2 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.6.2.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.6.3 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.6.4 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.7 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.2 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.7.2.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.7.3 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.7.4 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Europe Brain Cancer Diagnostics Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.1 Organic Developments

12.1.1 Overview

12.2 Inorganic Developments

12.2.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Biocept, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Koninklijke Philips N.V.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Canon Medical Systems

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Hitachi, Ltd.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Neusoft Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type US$ Mn)

Table 2. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test US$ Mn)

Table 3. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 4. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 5. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 6. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 7. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 8. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 10. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 11. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 12. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 13. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 14. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 15. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 16. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 17. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 18. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 19. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by Cancer Type (USD Million)

Table 20. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by End User (USD Million)

Table 21. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 22. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 23. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 24. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 25. Organic Developments in the Brain Cancer Diagnostics Market

Table 26. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 27. Glossary of Terms, Brain Cancer Diagnostics Market

LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. Europe Brain Cancer Diagnostics Market Overview

Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4. Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Brain Cancer Diagnostics Market - Europe PEST Analysis

Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7. Europe Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe: Brain Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 28. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 29. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. Germany Brain Cancer Diagnostics Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35. Impact of COVID-19 Pandemic in European Country Markets

Figure 36. Growth Strategies Done by the Companies in the Market, (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe brain cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample